NCT05116085 2026-02-13Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Participants With Colorectal CancerBeOne MedicinesPhase 2 Completed33 enrolled 11 charts
NCT04666688 2025-02-12LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid TumorsPureTechPhase 1/2 Completed44 enrolled